MedTrace Logo

McGill Exercise With and Without 3-dimensional Myofascial Release Technique in Non-specific Low Back Pain

NCT07441031 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-02-27

No results posted yet for this study

Summary

Low back pain is a complex of musculoskeletal disorders or muscular imbalance and one of the most common problems of patients referred to physiotherapy clinics, but still diagnosis and especially the provision of special back pain therapy is a challenge. According to the studies, 84% of the population at least once in a lifetime. Non-specific Lower back pain NSLBP does not have any specific cause and almost 90% of patients experience undiagnosed pathologic LBP. It is multifactorial and has different causes depends on the type of injury. Common etiologies behind NSLBP are muscular weakness, postural instability, fascial restriction, lumbo-pelvic muscle imbalance, change in spinal curvature and abnormal tilting of pelvic.

Conditions

  • Exercise
  • Low Back Pain
  • Lumbar
  • Lordosis

Interventions

OTHER

McGill exercise with 3 D Myofascial Release.

Treatment will include McGill's big 3 core exercises initially 2 sets of 10rep then progress with increasing sets and repetitions. And 3-D Myofascial release stretches, each for 90sec. 1 set of 3rep in every physiotherapy session. Patient will get 3 sessions of 40-45minutes, per week for 6 weeks.

OTHER

McGill exercise without 3-D MFR

Perform McGill's big 3 core exercises initially 2 sets of 10rep then progress with increasing sets and repetitions. Patient will get total 3 sessions per week of 40- 45minutes for 6 weeks.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Faiza Taufiq · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-15
Primary Completion
2026-01-05
Completion
2026-01-05

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07441031 on ClinicalTrials.gov